PROFOUND MEDICAL CORP.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $2.5M | — | $5.3M | — | — | — | $5.3M |
| Cost of Revenue | — | $536.0K | — | $1.5M | — | — | — | $1.4M |
| Gross Profit | — | $1.9M | — | $3.8M | — | — | — | $3.9M |
| Gross Margin | — | 78.4% | — | 71.8% | — | — | — | 74.3% |
| Operating Expenses | ||||||||
| Research & Development | — | $5.7M | — | $5.3M | — | — | — | $5.4M |
| SG&A Expense | — | $7.4M | — | $6.6M | — | — | — | $7.4M |
| Operating Income | — | $-11.1M | — | $-8.0M | — | — | — | $-8.9M |
| Operating Margin | — | -445.7% | — | -150.3% | — | — | — | -168.5% |
| Interest Expense | — | — | — | $80.0K | — | — | — | — |
| Pretax Income | — | $-9.5M | — | $-7.0M | — | — | — | $-7.9M |
| Income Tax Expense | — | $55.0K | — | $25.0K | — | — | — | $121.0K |
| Net Income | — | $-9.5M | — | $-7.1M | — | — | — | $-8.0M |
| Net Margin | — | -384.2% | — | -132.2% | — | — | — | -150.8% |
| EPS (Basic) | — | $-0.26 | — | $0.19 | — | — | — | $0.26 |
| EPS (Diluted) | — | $-0.26 | — | $0.19 | — | — | — | $0.26 |
| Shares Outstanding (Basic) | 36.5M | 36.4M | 36.3M | 36.3M | 36.3M | 36.3M | 30.2M | 30.1M |
| Shares Outstanding (Diluted) | 36.5M | 36.4M | 36.3M | 36.3M | 36.3M | 36.3M | 30.2M | 30.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |